BioCentury | Oct 20, 2014
Company News

Metamark Genetics sales and marketing update

...prostate cancer biopsy test in the U.S. to improve prognosis accuracy. Metamark, which acquired the HealthTronics...
BioCentury | Mar 17, 2014
Company News

Intrexon management update

...SVP and head of Intrexon's consumer sector, a newly created position, formerly president at the HealthTronics Inc....
BioCentury | Jan 20, 2014
Company News

Endo, Altaris Capital Partners LLC deal

...up front, plus up to another $45 million based on HealthTronics' future operating performance. The HealthTronics...
...close this quarter. In August 2013, Endo said HealthTronics was selling its anatomical pathology business, HealthTronics...
...for an undisclosed amount. In June 2013, Endo announced it would seek alternatives for the HealthTronics...
BioCentury | Oct 7, 2013
Company News

Metamark Genetics management update

...Business: Diagnostic Hired: Cornelius Merlini as SVP and chief commercial officer, formerly general manager of HealthTronics...
BioCentury | Aug 19, 2013
Company News

Endo, Metamark Genetics deal

...Endo said its HealthTronics Inc. subsidiary will sell its anatomical pathology business, HealthTronics Laboratory Solutions Inc., to...
...Metamark for an undisclosed amount. In June, Endo announced it would seek alternatives for the HealthTronics...
...revenues of $11 million for the six months ending June 30 (see BioCentury, June 10). HealthTronics...
BioCentury | Jul 1, 2013
Finance

2Q Stock Wrap-Up: If it ain't broke

...as R&D projects with near-term revenue potential. The company is seeking strategic alternatives for its HealthTronics...
BioCentury | Jun 10, 2013
Company News

Endo neurology news

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...
BioCentury | Jun 10, 2013
Finance

Highlights of weekly biotech stock moves

...operating expenses by mid-2014. The company also said it will seek strategic alternatives for its HealthTronics...
BioCentury | Jun 6, 2013
Company News

Endo restructures, lowers guidance

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...
BioCentury | Apr 18, 2011
Company News

American Medical Systems Holdings Inc., Endo deal

...prostate cancer treatment Vantas histrelin, and urology services and technology from last year's acquisition of HealthTronics Inc....
Items per page:
1 - 10 of 15
BioCentury | Oct 20, 2014
Company News

Metamark Genetics sales and marketing update

...prostate cancer biopsy test in the U.S. to improve prognosis accuracy. Metamark, which acquired the HealthTronics...
BioCentury | Mar 17, 2014
Company News

Intrexon management update

...SVP and head of Intrexon's consumer sector, a newly created position, formerly president at the HealthTronics Inc....
BioCentury | Jan 20, 2014
Company News

Endo, Altaris Capital Partners LLC deal

...up front, plus up to another $45 million based on HealthTronics' future operating performance. The HealthTronics...
...close this quarter. In August 2013, Endo said HealthTronics was selling its anatomical pathology business, HealthTronics...
...for an undisclosed amount. In June 2013, Endo announced it would seek alternatives for the HealthTronics...
BioCentury | Oct 7, 2013
Company News

Metamark Genetics management update

...Business: Diagnostic Hired: Cornelius Merlini as SVP and chief commercial officer, formerly general manager of HealthTronics...
BioCentury | Aug 19, 2013
Company News

Endo, Metamark Genetics deal

...Endo said its HealthTronics Inc. subsidiary will sell its anatomical pathology business, HealthTronics Laboratory Solutions Inc., to...
...Metamark for an undisclosed amount. In June, Endo announced it would seek alternatives for the HealthTronics...
...revenues of $11 million for the six months ending June 30 (see BioCentury, June 10). HealthTronics...
BioCentury | Jul 1, 2013
Finance

2Q Stock Wrap-Up: If it ain't broke

...as R&D projects with near-term revenue potential. The company is seeking strategic alternatives for its HealthTronics...
BioCentury | Jun 10, 2013
Company News

Endo neurology news

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...
BioCentury | Jun 10, 2013
Finance

Highlights of weekly biotech stock moves

...operating expenses by mid-2014. The company also said it will seek strategic alternatives for its HealthTronics...
BioCentury | Jun 6, 2013
Company News

Endo restructures, lowers guidance

...and R&D projects with near-term revenue potential. The company will seek strategic alternatives for its HealthTronics...
BioCentury | Apr 18, 2011
Company News

American Medical Systems Holdings Inc., Endo deal

...prostate cancer treatment Vantas histrelin, and urology services and technology from last year's acquisition of HealthTronics Inc....
Items per page:
1 - 10 of 15